Bovine respiratory disease treatment market value

According to Technavio’s analyst, the global BRD treatment market is anticipated to grow at a steady rate and will post a CAGR of more than 8% during the forecast period. The development of novel products and launch of new products will increase the adoption rates and drive the growth prospects for the global bovine respiratory disease (BRD) treatment market until the end of 2021. One of the major factors responsible for the market's growth is the increasing interests of several vendors on the development of novel drugs to gain a competitive advantage over their competitors. For instance, Bayer HealthCare launched Zelnate in the US, which is a bacterial-produced plasmid DNA including a liposome carrier that helps to stimulate the innate immune system in cattle. Furthermore, under traditional antibiotics segment also, vendors are launching various drugs such as draxxin for the cattle respiratory disease treatment.

Get A Free Sample

The growing focus on the development of combination drugs will drive the growth prospects for the global BRD treatment market for the next few years. Some of the major factors responsible for the growing number of development of combination drugs is the need to offer improved efficacy and ensure better treatment outcomes.

BRD treatment market report: Competitive landscape and key vendors

The global BRD treatment market is highly competitive and diversified due to the presence of a large number of regional and international vendors across the globe. It has been observed that these vendors are increasingly competing against each other based on factors such as aggressive pricing, novel therapeutics, and advancements in technology. Also, according to the industry research report, a large number of vendors are increasingly forming strategies to increase their market share and remain competitive in the cattle respiratory disease treatment market. Furthermore, the competition will further increase with the development of novel therapeutics such as DNA immunostimulants.

Key vendors in this market are

• Bayer HealthCare
• Boehringer Ingelheim
• Elanco
• Merck
• Zoetis

Other prominent vendors in the market include Bimeda, Ceva, Huvepharma, Inovio Pharmaceuticals, Med-Pharmex, Norbrook Laboratories, and Plumbline Life Sciences.

Segmentation by product category and analysis of the BRD treatment market

• Antibiotics
• Vaccines

The antibiotics segment accounted for the majority market share during 2016 and will continue to dominate the market for the next four years. Some of the major factors responsible for the market segment's growth is the increasing incidence of BRD, growing focus of vendors to develop combination treatments, and the focus of vendors to develop antibiotics.

Segmentation by geography and analysis of the BRD treatment market

• Americas
• APAC
• EMEA

In terms of geography, the Americas accounted for the majority market share during 2016 and will continue to dominate the market during the forecasted period. Some of the major factors responsible for the growing adoption of cattle respiratory vaccines in the region is the increasing demand for livestock products and growing BRD cases, which is one of the costly diseases of beef cattle in North America. Also, the growing technological advancements and established clinical evidence regarding the efficacy of this drug will further drive the adoption of vaccines by veterinarians and producers for the treatment of BRD.

Key questions answered in the report include

• What will the market size and the growth rate be in 2021?
• What are the key factors driving the global bovine respiratory disease (BRD) treatment market?
• What are the key market trends impacting the growth of the global bovine respiratory disease (BRD) treatment market?
• What are the challenges to market growth?
• Who are the key vendors in the global bovine respiratory disease (BRD) treatment market?
• What are the market opportunities and threats faced by the vendors in the global bovine respiratory disease (BRD) treatment market?
• What are the trending factors influencing the market shares of the Americas, APAC, and EMEA?
• What are the key outcomes of the five forces analysis of the global bovine respiratory disease (BRD) treatment market?

Technavio also offers customization on reports based on specific client requirement.

Related reports:

• Global Pompe Disease Treatment Market 2016-2020
• Global Factor IX Deficiency Treatment Market 2017-2021
• Global Factor VIII Deficiency Treatment Market 2017-2021
• Infectious Disease Treatment Market in China 2016-2020